Form 4: Sutro Biopharma Executive Reports Stock Transactions
SEC Form 4 Filing
Venkatesh Srinivasan, Chief Technical Operations Officer of Sutro Biopharma, reports the vesting and subsequent tax withholding of shares related to restricted stock units.
Summary
- On April 11, 2025, Venkatesh Srinivasan, the Chief Technical Operations Officer of Sutro Biopharma, engaged in transactions involving the company's common stock.
- These transactions included the vesting of 21,250 restricted stock units (RSUs) and the withholding of 7,603 shares to cover income tax obligations.
- Following these transactions, Srinivasan directly owns 52,080 shares of Sutro Biopharma common stock and 21,250 RSUs.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive compensation and does not inherently indicate positive or negative sentiment. It's a neutral event.
Industry Context
This is a standard SEC Form 4 filing, reflecting changes in beneficial ownership by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.
Key Dates
| Date | Description |
|---|---|
| 04/11/2023 | RSUs vest as to 1/4th of the total award annually beginning on this date, subject to continued service through each vesting date. |
| 04/11/2025 | Date of the reported transactions: vesting of RSUs and tax withholding. |
| 04/11/2026 | Expiration date of the RSUs. |
| 04/15/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Sutro Biopharma, STRO, Venkatesh Srinivasan, Chief Technical Operations Officer, Stock Transactions, Restricted Stock Units, RSU, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.